IndieBio – now operating out of both San Francisco and New York – is proud to announce our new batches of startups. This is New York’s first batch, and San Francisco’s tenth. Though we are running the program virtually for now, all of the startups have secured access to lab and hardware space as needed. […]
At IndieBio, our perspective on gut bacteria is informed not just by the companies we’ve invested in that do human microbiome science, but by all the companies in our portfolio who work with bacteria and biomes in diverse sectors from the Future of Food to the Future of Energy to Biomaterials to Agriculture. Early Popularization […]
Cookie Policy This page, with our Privacy Statement, details our use of cookies on this website (the “Website”). By using the Website, you indicate that you accept the terms of this Cookies Policy and our Privacy Policy and you agree to abide by them. If you do not agree to these, please do not use […]
Privacy Policy 1. Introduction SOSV Limited, a limited liability company incorporated under the laws of Ireland with registered number 433655 and together with its affiliates (“SOSV”, “we”, “us” or “our”), respects your privacy and personal data. This statement describes what personal data we collect and how we use, process and disclose such personal data. Personal […]
IndieBio helps entrepreneurs build ground-breaking biotech companies. We’re excited to share our ninth class of 11 new startups. They have been here for thirty days, working tirelessly to derisk critical pieces of their science and business. The four month program will culminate in a Demo Day on the 6th of February. AgriSea is creating methane-negative […]
There’s thousands of ways that cells become unhealthy. But until 2012, there were only two ways that cells actually die. That year, the cofounder of Prothegen, Dr. Scott Dixon, discovered a new way cells die, called ferroptosis, an iron-mediated failure of antioxidant defenses. Now Dixon has partnered with Roche alum Davide Zanchi and chemist Derek […]
New York is a global center of cultural and economic affairs, such as theatre, food, fashion, and international business. At Unexpected Biotech, IndieBio featured 2 founders who envision a future where biomaterials becomes yet another area for which New York is famous. What advantages does a biomaterials startup have on the east coast? And how […]
Stembionix is creating the biofabrication infrastructure necessary to grow organs from stem cells. Their innovative vascularization technology is built with the goal of surmounting the challenge of culturing organoids: namely, growing organs larger than 8 mm diameter, at which point the internal cells lose nutrient access and die. Their vascularization technology is complemented by other […]
BioFeyn is a company that aims to make farmed fish a truly sustainable practice. We spoke with CEO Timothy Bouley to learn more about how nanotechnology can create better fish. Watch and read an abbreviated version of the conversation below. What are the problems with current farmed fish practices? There are many ingredients used in […]
The immune system is fine tuned to defend the body from foreign invaders, but when the system malfunctions it can spell disaster for a person’s health and quality of life. The panelists of IndieBio’s Biotechnology x Immunology event are using biotechnology to offer solutions to those suffering from immune dysregulation and overactivity. Read the top […]
Despite the demand from consumers and environmental benefit, organic agriculture accounts for less than 2% of global agricultural land. Reazent is on a mission to change this by providing biologic products to supercharge plant growth and crop yields. Despite being a young company, they extensive field trials showing the benefit and consistency of their product, […]
We just had our Demo Day and we’re excited to share the recording of the livestream here. We vet the newest and exciting technologies that will make a big impact on our planet. We’ve been working with these 13 companies because they hit our bar for quality, so you know you’re always watching the cream […]
There is a major funding gap for very early stage bio-entrepreneurs. Backed by SOSventures, a $200million dollar VC fund, IndieBio is the world’s first accelerator dedicated to early stage biology startups. We’re offering a total package of $100k, including $50k in cash, IndieBio, a dedicated biolab in San Francisco, brings together the world’s leading scientists […]
Traditionally, humans have exploited biology to produce appealing foods via selective breeding of livestock and crops. Yet there remains an unmet demand for sustainably sourced, optimally nutritious foods–a demand that can only be met with biotechnology. Food biotechnology unites the best of what biotech has to offer by providing solutions for both human and planetary […]
We are seeking up to 8 startups to receive a minimum of $250,000 each to pursue the development of diagnostics, therapeutics, vaccines, disinfection, and other solutions addressing the worldwide problem of emerging infectious diseases. We have an unprecedented opportunity to contribute to solving the remarkable scale of challenges that Covid-19 presents to our planet. Scientists […]
Arvind Gupta, Managing Director & Founder of IndieBio: Meeting the challenge of climate change is commonly characterized as a tradeoff with industrial economic growth. In order to save the planet, we have to reduce consumption, and we have to stop production, and we have to give up behaviors we’ve long been accustomed to. The party’s […]
On Conscious Leadership: Jack Sim By his count, before he turns 80 and is confined to a wheelchair and can’t remember his wife’s name, Jack Sim has 6,734 days left to live. Less than one thousand weeks. He counts his days in order to focus, in order to make it count. Today, he’s at IndieBio, […]
The science of gene therapy poses one of the greatest technical challenges in modern medicine. Researchers and industry face the significant challenge of introducing new functioning genes into cells, and doing so in a scalable and affordable manner. Indee is a biotech startup developing new tools for gene therapy to bring it to the masses. […]
Gwen speaks with Pablo Zamora, Co-Founder and original CSO of NotCo. From their website: “When we discovered removing animals from food production would protect the planet, the solution was simple: create an algorithm – that we named Giuseppe – who could learn infinite combinations of plants to replicate animal products, make them sustainable and taste […]
IndieBio and the National Institute on Drug Abuse (NIDA ), part of the U.S. National Institutes of Health (NIH) are excited to announce a historic new collaboration aimed at accelerating the formation of biotech startups which will tackle the issues of drug abuse and addiction in the USA via the “$100K to Start a SUD […]
Inso Bio is solving the biggest bottleneck in genomic analysis: DNA extraction. This process currently takes highly skilled scientists several hours to complete, which Inso Bio can decrease to a 40 minute automated process. Watch Inso Bio present at IndieBio NY Class 3 Demo Day We spoke with CEO Harvey Tian, Ph.D., about the Inso […]
RizLab Health is addressing the pandemic of antimicrobial resistance and helping clinicians by pinpointing the source of infection (and thus preventing inappropriate antibiotic prescriptions) with their point-of-care device, the CytoTracker. The CytoTracker differentiates bacterial from viral infection profiles within minutes. A 200-person clinical study demonstrated the CytoTracker beats the specificity of current testing methods, making […]
In the article, “Materials Innovator AlgiKnit Closes $13 Million Series A Thttps://www.synbiobeta.com/read/materials-innovator-algiknit-closes-13-million-series-a-to-transform-the-textile-industrys-environmental-impacto Transform the Textile Industry’s Environmental Impact,” SynBioBeta reports that biomaterials company AlgiKnit (IndieBio / RebelBio 05) has completed a $13 million Series A funding round led by Collaborative Fund with additional support from Starlight Ventures, Third Nature Ventures, Horizons Ventures, and SOSV. Just Style’s article “H&M Group joins funding for seaweed yarn maker Algiknit” also […]
From lab-grown fish to burger flipping robots, Hulu’s new six-episode docu-series “The Next Thing You Eat” will explore the changes in what we eat. To help advance that discussion, co-founder and CSO Ellen Jorgensen of Aanika Biosciences (SOSV RebelBio) joins an episode to explain how they use microbes to trace and authenticate products in the […]
IndieBio SF’s Demo Day was a huge success! We started off the day with an online demo day at 10 AM PST with incredible videos made by the IndieBio SF team in collaboration with the founders, as an exercise to hone the narrative of the company, ensuring that differentiation is coming across to investors. Some […]
It was definitely a night to remember! After months of hard work, many came together to celebrate the milestones and accomplishments our Class 04 companies achieved during our Spring 2022 program. The event began with opening remarks from Joan Spivak, Senior Director, Life Sciences for Empire State Development, an organization that we are proud to partner […]
Bloomberg Quicktake recently tweeted a video highlighting three companies revolutionizing the alt-egg industry—one of which is IndieBio’s EVERY Company (IndieBio SF01 2015). The EVERY Company creates an animal-free egg white replacement using precision fermentation to mimic the characteristics of egg, including foaming, gelation, and nutritional properties. Bloomberg Quicktake interviewed EVERY founder and CEO Arturo Elizondo […]
The Financial Times recently released a video titled “Fermenting: the future of animal-free meat?” in which Financial Times’ San Francisco correspondent Dave Lee interviewed IndieBio founders Arturo Elizondo from The EVERY Company (SF01 2015) and Kimberlie Le from Prime Roots (SF06 2018) to learn how precision fermentation is a significant contender in the alternative egg […]
Biomaterials company BioAesthetics (IndieBio 05) has been developing a nipple-areolar complex (NAC) graft for breast cancer survivors, and New Orleans 4WWL TV News tells the story of the first successful graft in, “Breast cancer survivor receives breakthrough nipple, areola reconstruction surgery”. Breast cancer survivors who have undergone mastectomies usually cannot keep their nipples and areolas […]
Consumers looking for meat alternatives love their nuggs and burgers, but no company has recreated the experience of a chicken cutlet or scallop in taste and texture. Bosque Foods leverages the power of fungi to create whole-cut meats to satisfy any vegan, vegetarian, or flexitarian using clean ingredients and minimal processing. We spoke with CEO […]
“There is a day coming where everyone on the planet will be touched by SOSV companies, every day,” SOSV Managing General Partner Sean O’Sullivan said in his opening remarks at the top of SOSV’s 2023 Annual General Meeting in New York City on June 1. “It’ll be in the clothes they wear, the food they […]
Climate change threatens to undermine agriculture at a moment when food production needs to increase, and quickly. The UN estimates that 1.3 billion people were food insecure in 2022, with most living in areas of Sub-Saharan Africa and Asia that are especially vulnerable to climate change. To feed a global population of 9.7 billion in […]
The $4.7 trillion chemical industry accounts for about 4% of global GDP and 5% of carbon emissions. The industry is proving hard to decarbonize due to its use of carbon-intensive feedstock (e.g., petroleum) and high heat in production. Solugen, valued at over $2B, aims to deliver the green solution. At the SOSV Climate Tech Summit […]
Back in 2012 if you had predicted that the climate tech startup category would be worth $2.6 trillion today, you would have been laughed out of the room. That year was the nadir of first “clean tech” investing wave, which poured some $25 billion into earth-saving startups. Less than half of that capital was returned according […]
Application FAQs
I was recently inspired by Jason Silva’s Captains of Spaceship Earth: “First we build the tools and then the tools build us” Biology, as a technology is accelerating, the technology that builds us and our environment, what many people don’t realize is that we use it everywhere and it’s only just beginning. From the moment you […]
Milk should be a delicious and protein-rich drink, but many alternatives to cow’s milk lack its nutrient depth. Upright has created the world’s first protein-rich, allergen-free, vegan oat milk option with double (or more!) the protein of other oat milks. Upright then improves on cow’s milk to include ingredients that promote gut, heart, and bone […]
Yesterday, IndieBio presented New York Batch 5 for an online Demo Day, an event that highlights new companies in the IndieBio fold. Unique to this year’s Demo Day was the location of the event: IndieBio’s new 25,000 sq. ft. office, lab, and event space at 7 Penn Plaza in New York City. IndieBio’s managing director […]
Bio-based materials are the future, and Tômtex is designing the petrochemical-free revolution. The New York-based startup has garnered awards from design schools and fashion competitions for its material, which uses seashell waste as its foundation. By using entirely green chemistries, Tômtex creates entirely biodegradable exotic leather substitutes with incredible strength and beauty. Watch Tômtex present […]
Beemmunity protects bees from the effects of both lethal and sublethal exposure to pesticides. Their ingestible microsponge technology absorbs all pesticides and allows them to be safely expelled without harm. Beekeepers can simply add this product to their current bee feeding processes to detoxify their bees. This prevents bees from the direct toxic effects of […]
Thank you so much to everyone who attended San Francisco’s Demo Day (virtually). We are so excited to present 13 companies who are impacting the future of human and planetary health. In case you missed it, you can watch the event, see company videos, and read the blogs by clicking here. If you are an investor and would like […]
“This is bone black” she said as she handed me a sample of jet black hair. Silky smooth, shiny, and knottable — the bundle of plant-based hair extensions was, unmistakably, hair. Aja Labs’ biodegradable, plant-based hair samples on display at IndieBio Batch 11’s Expo on 12 July 2021 Co-founded by Osahon Ojeaga and Suna Lumeh, […]
There’s no doubt that the biotech industry has grown rapidly in New York City in the past decade. The landscape has changed from the domination of a few large pharmaceutical companies to a wide array of many biotech companies. Some New York-based startups, like Kallyope, have grown from a few founders to a team of […]
Harmony Baby Nutrition makes baby formula that more closely represents human breast milk than any other formula on the market. Their secret? Precise fermentation of human breast milk protein to replace commonly used cow’s milk. One in five infants has an allergy to cow’s milk protein, which means one in five infants cannot use standard […]
Free to Feed helps breastfeeding mothers with allergic babies. Breastfeeding babies can react to allergens passed through the mother’s milk, and Free to Feed provides solutions to pinpoint the allergenic source. The current “breast friend” model offers one-on-one consulting to help mothers identify the source in a couple months. Their forthcoming test kit is tailored […]
MicroTERRA grows lemna with fish farmers to recycle pollution and feed the world. Lemna, also known as duck weed or water lentil, uses the nitrogen and phosphorus in the fish waste as fertilizer, preventing these nutrients from growing to toxic concentrations. It contains up to 40% protein and up to 25% pectin, an ingredient known […]
Bucha Bio grows their biomaterial with bacteria, free from animals or any plastic additives. Their biomaterial can be personalized in every different way: colors, textures, and other new traits. Their expected production cost at scale is lower and production speed is faster than any leather companies that are in the market. And they are providing […]
Nyoka Design Labs produces biodegradable light wands with bioluminescence to replace toxic chemical glow sticks. Their cell-free, enzyme-based light wands are shelf stable and meet industry standards for brightness and duration. They are now selling these light wands for commercial uses, such as events and festivals, with plans to expand into industrial uses such as […]
BrickBuilt Therapeutics is the first company targeting the microbiome via live biotherapeutic products to treat oral diseases. They are replacing conventional therapies—surgery or broad spectrum antibiotics—with bacterial strains isolated and formulated specifically to treat oral diseases. BrickBuilt’s first preclinical candidate microbial drug targets periodontitis, or gum disease. This targeted treatment will not only create a […]
Kutanios produces a peptide-based ingredient that prevents sun damage and aging via topical application. The novel mechanism stops skin cells from degrading the surrounding collagen and promoting inflammation, common causes of sun-damage related aging. Not only does this peptide protect against sun and skin damage, but their ingredient is biodegradable and safe for the environment. […]
Sequential Skin uses their unique at-home test to provide the world’s first truly personalized skin care. Their test considers both the human genetics and the skin microbiome to generate a report tailored to the individual. Years of research have indicated that the skin microbiome, and specifically the diversity (how many different types of microorganisms), are […]
A New York-based startup is about to commercialize the first true innovation in disinfection since Louis Pasteur. The startup, Halomine Inc, was founded by Mingyu Qiao and Ted Eveleth, and their first product, HaloFilm™, extends the lifetime of bleach on surfaces from minutes to weeks. At the start of the pandemic, we at IndieBio were really […]
The future is in fermentation, but what does that mean to benchtop scientists who want to produce consumer or therapeutic products at industrial scale? During the IndieBio-produced event, Unexpected Biotech, IndieBio NY Managing Director Stephen Chambers spoke with Stuart Wilkinson, Co-Founder and Technology Director of BioBrew. The conversation broke down several myths of startup scale […]
Explore the “New Biotech” with the IndieBio team and learn how we can re-imagine, re-materialize, and rebuild the world together. As a traditional natural science, biologists used microscopes to better understand the human body. “A lot of therapeutics have been observations through nature. Like finding a tree bark and turning that into a drug,” CSO […]
Cells send “danger” signals to alert the immune system when they are under attack. Under the wrong conditions, these signals can lead to chronic inflammation and many downstream pathologies, including chronic pain. Pannex Therapeutics stops the production of one of these danger signals—extracellular ATP—by blocking a protein called the Pannexin 1 channel, which sends ATP […]
IndieBio NY Demo Day was a huge success! The 10 graduating startups gave 3-minute presentations on the huge problem they are tackling in human or planetary health, their technical product that solves the problem, and the opportunity for immense impact for good when these startups succeed. Thank you for all the enormous support to our […]
Ceragen produces probiotics for plants that help crops grow faster and bigger. Their unique discovery platform allows Ceragen to identify the ideal microbial consortia for each crop type, including crops like tomatoes and lettuce. Watch Ceragen present at IndieBio NY Class 3 Demo Day We spoke to CEO Danielle Rose about the importance of producing […]
CRISPR may be a Nobel Prize winning discovery, but its translation into a therapeutic use raises many questions on safety, edit specificity and their consequences. In CRISPR, a short RNA (guide RNA) navigates the Cas enzyme to make the edit in the right place, and this gRNA plays a critical role in safety. Helex’s novel […]
Allied Microbiota is a company using bacteria that literally eat pollution for lunch to clean contaminated soils and turn brownfields into green fields. We spoke with CEO Lauralynn Kourtz about the discovery of the Allied Microbiota strain, ThermO+™. Watch and read an abbreviated version of the conversation below. What compounds are in contaminated soils and […]
Cardiac arrest is one of the most time critical conditions that can strike anywhere. For the patient, each minute until the ambulance arrives has a huge impact on survival and future medical complications. Ember Medical is solving this by connecting the millions of high-risk patients with CPR-trained medical professionals in the community. Their app alerts […]
Undergoing clinical studies at Stanford right now in prostate cancer, Filtricine
Today, we stand on the brink of the fourth industrial revolution which fuses the physical, digital and biological spheres of technology that will fundamentally alter the way we all treat our health, eat sustainable and live better. This revolution which is being built by hundreds of startups around the world will have a biological base. IndieBio […]
The management guru, Peter Drucker, is said to have remarked, “You can’t improve what you don’t measure.” This certainly applies to continuous biological measures from wearable technologies. In recent years, these cool tools have helped us gain a fuller measure – and therefore improvement – of various aspects of our personal health and wellbeing. Continuous […]
A third of the world’s agricultural soil is degraded by drought, high salinity and the increasing effects of climate change. Without bold innovation, we will soon run out of healthy arable soil sufficient to feed the planet. Puna Bio repairs and restores soil health using their proprietary extremophiles – organisms 3.5 billion years old, sourced […]
Portable artificial kidneys, smaller than a backpack
We’re excited to announce our eighth class at IndieBio. IndieBio invests in revolutionary technologies for human and planetary health, and each of these companies, though small today, has tremendous potential to become a very significant and disruptive company. We selected them from well over 300 who applied from all over the world. Over the next […]
Photo: The NeuroQore team (Mehran on far left). Depression is a major burden in many people’s lives who we know. Some of the treatments that are prescribed, like medication, are not always effective or without major side effects. Drug-resistant depression is sometimes treated with electroshock therapy, which is risky, despite being the gold standard. In […]
IndieBio’s cultured meat startup Prolific Machines has emerged from stealth mode, announcing $42M in combined seed and series A funding. Prolific Machines started in SOSV’s IndieBio development program, and Arvind Gupta at Mayfield (previously co-founder of IndieBio) led the $3.1M seed round, followed by the series A led by Breakthrough Energy Ventures. TechCrunch described how […]
Now in its second year, the SOSV Climate Tech 100 is shaping up to be a great showcase for SOSV’s climate tech mission and investing. More than half of the companies on the list—58 to be exact—graduated from IndieBio. In the past year, the 100 have doubled in valuation, reaching more than $11 billion, and […]
Deli and groceraunt meals using fungi proteins.
NURO is the architect of the NUOS product line allowing Communication by Brain. Instantly and without any surgery.
Brightcure is a company dedicated to improving women’s health. We asked Brightcure CEO Chiara Heide questions about the first product, a bioactive cream that promotes a healthy microbiome in a woman’s urogenital tract. Watch and read an abbreviated version of the conversation below. Your personal story lends a lot of motivation. Will you please share […]
We’re delighted to announce that IndieBio is partnering with the World Agri-Tech Investment Summit! This year more than 400 international ag technology leaders, innovators, and investors will gather in San Francisco on March 16-17th. This year’s theme is “Connecting Business and Technology to Create Scalable Innovation” and already an outstanding faculty of speakers have confirmed their participation, including: Jim […]
This is an example page. It’s different from a blog post because it will stay in one place and will show up in your site navigation (in most themes). Most people start with an About page that introduces them to potential site visitors. It might say something like this: $3.4B+ Value Created 159 Companies Funded […]
Today we’re delighted to announce our partnership withSpaceGAMBIT to accelerate Space Biology, we believe one of the weakest links in making humanity a multi-planetary species is the understanding and development of biotechnologies which could be deployed in every aspect of life in space. In this partnership, IndieBio will be supportingSpaceGAMBIT with open source capacity building biotechnologies that […]
I believe that computing shall be even more pervasive and ubiquitous than it is today and will evolve into a high-impact, use-inspired basic science1. Over the last seven decades, we have seen the beginning of a major technological revolution, the Information Revolution. Many of us who are middle-aged or part of the baby-boomer generation have […]
Media Contact: Dorothy Lou Bailey, dorothylou@transcriptic.com San Francisco, CA – IndieBio, the leading global biotech accelerator, today announced an exclusive partnership with the robotic cloud laboratory platform Transcriptic for up to $60,000 per year in free services for the companies they fund and accelerate. The Transcriptic credits will be divided evenly among the companies in […]
Drug delivery is one of the greatest challenges in treating cancer today. There are a multitude of effective drugs that aren’t able to be delivered to tumor sites, or can not be delivered in combination. Vali Nanomedical is now solving these drug delivery problems with a revolutionary programmable drug delivery system, and working towards a […]
In recent years we’ve seen an exponential ability to sequence DNA. What in the recent past it cost billions of dollars is now available for under one thousand dollars. However, the cost of synthesizing new DNA is still prohibitive and causing bottlenecks in research and industry. Genesis DNA is working to create new methods to […]
SOSV Announces Launch of IndieBio New York — World’s leading life sciences accelerator expands to New York City —— Call for Applications Open Now — (NEW YORK, January 7th, 10:30am EST) — SOSV, the world’s most active investor in both life sciences and hardware, announced that the inaugural cohort of IndieBio New York will start […]
The science of skincare hasn’t changed for 100 years. As we learn more about the skin, new opportunities for innovation are being uncovered that will shift the industry’s approach to beauty. Nerd Skincare is leveraging these advancements in science to innovate safer and better skincare products. I talked to the company’s CEO, Evelyn Chen, to […]
Cellular protein production is used across industries to create products for medicine, consumers, research, and more. However, the technology to do so in the most efficient and effective ways has lagged behind production. Circularis is using their expertise in discovering, analyzing, and evolving cellular promoters in order to regulate protein production with revolutionary precision. I […]
Tracking vital signs is a crucial means for preventing disease. However, it’s a big time demand on caretakers of the most vulnerable patients and rarely done for much of the general population. V-Sense is developing monitors using NASA Jet Propulsion Lab radar technology to remotely and continuously monitor key vital signs. I talked to the […]
Next-generation DNA sequencing technology has revolutionized biological research over the last decade, but very few advancements have been made in proteomics, the next great frontier of biological data. MYi is developing these new methods to study proteins in order to better understand, manage, and cure disease. I spoke with Jun, the company’s COO, to learn […]
Modern neuroscience is still relying on old methods that don’t allow us to truly understand what’s happening in the brain in real-time. As a result, we have a limited understanding of brain-related disease and ability to treat conditions early. Truust’s neuroimaging technology is providing real-time data in order to visualize energy flow in the brain, […]
The immune system is the cornerstone of our health and ability to fight disease, but there are no methods to truly monitor its status. As a result, medicine is forced into being reactive to illness, rather than fighting disease before it starts. Girihlet is working towards a future where the immune system is monitored at […]
Maria Soloveychik is the CEO and co-founder of SyntheX Labs, a biotech company developing peptide therapeutics for cancer and other rare diseases. A: Tell me about your background, how did you get interested in the biotech space? M: So it started in 8th when I decided I wanted to do biology so I could clone […]
The list of uses for recombinant proteins continues to grow as they are used in consumer, medical, and research markets. This increased use means that issues of scale, cost, and output efficiency must be addressed. Geltor is creating a new recombinant protein production platform to solve these problems. I talked to the company’s CEO, Alex Lorestani, […]
San Francisco, CA—SOSV/IndieBio, a leading venture capital firm focused on deep tech investments, is proud to announce several collaborations between its 200+ portfolio companies. The firm’s investments have been at the bleeding edge of innovation, and these collaborations further highlight the ingenuity of its founders and the potential for revolutionary new ideas. “We crowdsourced ideas […]
Note: This event took place from February 26 to March 8, 2024. For the next matchup, please sign up here. SOSV’s free and virtual 2024 VC-Founder Health Tech Matchup just opened for registration. We expect 300 investors and 500 founders to participate. Who is this for? Investors and founders in health tech, up to series […]
Presenting the deepest (and most exciting!) of deep tech: IndieBio SF’s 15th cohort!
ZymoChem is breakthrough science for a fossil-free future. We develop bio-based materials for everyday products without compromising Cost, Performance, Scale, or Sustainability. Since 2015, ZymoChem has refined its processes and patented technologies to replace petroleum ingredients and become one of the world’s most efficient biomanufacturing platforms. Materials underpinning our lives are made from fossil inputs with […]
In this session, Gwen interviews Gianna Hoffman-Luca, Principal from Xontogeny, a therapeutics focused seed-stage VC fund founded by Chris Garabedian, former CEO of Sarepta. Gianna demystifies the funding landscape for therapeutics startups, recommends companies to start solving for data necessary for series A funding, at the seed and pre-seed stage.
.